Diuretic Therapy for Bilateral Foot Swelling in Patients with Kidney Disease

Recommended Diuretic Options

The American Heart Association recommends Chlorthalidone at a low dose of 12.5 mg once daily as the preferred low-dose diuretic for patients with bilateral foot swelling and a history of kidney disease, due to its prolonged half-life and proven cardiovascular disease reduction 1, 2
Chlorthalidone is effective at low doses even in patients with mild-to-moderate kidney disease, and its use is associated with a reduced risk of cardiovascular events 1, 2
The American College of Cardiology recommends monitoring for hyponatremia, hypokalemia, and changes in uric acid and calcium levels in patients taking Chlorthalidone 2

For patients with moderate-to-severe CKD (GFR <30 mL/min), the American College of Cardiology recommends the use of loop diuretics over thiazides, with Torsemide, Bumetanide, and Furosemide being suitable options 2, 6
The British Journal of Pharmacology recommends checking electrolytes and renal function within 1-2 weeks of initiation of diuretic therapy, and adjusting dosing based on response and kidney function 7

The British Journal of Pharmacology recommends starting with the lowest effective dose and titrating slowly to minimize the risk of acute kidney injury, and combining diuretics with moderate dietary sodium restriction for optimal effect 7, 5, 3
The American College of Cardiology recommends avoiding potassium-sparing diuretics in patients with significant CKD (GFR <45 mL/min) due to the risk of hyperkalemia 2, 6